F. Miraki-Moud

发表

Loss of imprinting at the 14q32 domain is associated with microRNA overexpression in acute promyelocytic leukemia.

Jacek Marzec, Jun Wang, J. Gribben, 2014, Blood.

masks the heterogeneity of leukemia-initiating cells mediated clearance of human repopulating cells - Anti-CD38 antibody

J. Gribben, J. Cavenagh, D. Lillington, 2013 .

Acute myeloid leukemia does not deplete normal hematopoietic stem cells but induces cytopenias by impeding their differentiation

J. Gribben, J. Cavenagh, D. Bonnet, 2013, Proceedings of the National Academy of Sciences.

Effects of recombinant human insulin-like growth factor I (IGF-I) therapy on the growth hormone-IGF system of a patient with a partial IGF-I gene deletion.

P. Hindmarsh, R. Baxter, Y. Hansson, 1999, The Journal of clinical endocrinology and metabolism.

Quizartinib-resistant FLT3-ITD acute myeloid leukemia cells are sensitive to the FLT3-Aurora kinase inhibitor CCT241736.

A. Faisal, M. Valenti, A. K. de Haven Brandon, 2020, Blood advances.

Interleukin-1beta (IL-1beta) and IL-6 modulate insulin-like growth factor-binding protein (IGFBP) secretion in colon cancer epithelial (Caco-2) cells.

S. Bernasconi, M. Street, I. Sanderson, 2003, The Journal of endocrinology.

Interleukin-1 (IL-1 ) and IL-6 modulate insulin-like growth factor-binding protein (IGFBP) secretion in colon cancer epithelial (Caco-2) cells

S. Bernasconi, M. Street, I. Sanderson, 2003 .

Interleukin-1 (cid:1) (IL-1 (cid:1) ) and IL-6 modulate insulin-like growth factor-binding protein (IGFBP) secretion in colon cancer epithelial (Caco-2) cells

S. Bernasconi, M. Street, I. Sanderson, 2003 .

Insulin-like growth factor-I deficiency caused by a partial deletion of the IGF-I gene: Effects of rhIGFmi therapy

M. Savage, A. Clark, C. Camacho‐Hübner, 1999 .

Acid-Labile Subunit Deficiency and Growth Failure: Description of Two Novel Cases

L. Metherell, A. David, M. Savage, 2010, Hormone Research in Paediatrics.

Final Height in Patients with Idiopathic Short Stature and High Growth Hormone Responses to Stimulation Tests

M. Savage, A. Moreira, C. Martinelli, 2006, Hormone Research in Paediatrics.

MYELOID NEOPLASIA Loss of imprinting at the 14q32 domain is associated with microRNA overexpression in acute promyelocytic leukemia

J. Gribben, D. Grimwade, B. Young, 2014 .

Pharmacokinetic studies of recombinant human insulin-like growth factor I (rhIGF-I)/rhIGF-binding protein-3 complex administered to patients with growth hormone insensitivity syndrome.

M. Preece, A. Rogol, H. Storr, 2006, The Journal of clinical endocrinology and metabolism.

Dehydroepiandrosterone (DHEA) replacement reduces growth hormone (GH) dose requirement in female hypopituitary patients on GH replacement

J. Monson, A. Brooke, C. Camacho‐Hübner, 2006, Clinical endocrinology.

Pseudo-precocious Puberty Caused by a Juvenile Granulosa Cell Tumour Secreting Androstenedione, Inhibin and Insulin-like Growth Factor-I

H. Storr, M. Savage, L. Perry, 2004, Journal of pediatric endocrinology & metabolism : JPEM.

Growth hormone therapy for non-islet cell tumor hypoglycemia.

P. Bouloux, L. Silveira, F. Miraki-Moud, 2002, The American journal of medicine.

Mesenchymal niche remodeling impairs hematopoiesis via stanniocalcin 1 in acute myeloid leukemia

J. Gribben, A. Abarrategi, J. Fitzgibbon, 2020, The Journal of clinical investigation.

Single cell analysis of clonal architecture in acute myeloid leukaemia

J. Gribben, P. Campbell, E. Papaemmanuil, 2018, Leukemia.

A randomized pilot study to investigate the effect of opioids on immunomarkers using gene expression profiling during surgery.

J. Gribben, A. Oksche, R. Petty, 2019, Pain.

Increased levels of insulin‐like growth factor binding protein‐2 in sera and tumours from patients with colonic neoplasia with and without acromegaly

S. Bustin, D. Lowe, S. Jordan, 2001, Clinical endocrinology.

A rapid method for analyzing serum pro-insulin-like growth factor-II in patients with non-islet cell tumor hypoglycemia.

A. Grossman, J. Monson, C. Camacho‐Hübner, 2005, The Journal of clinical endocrinology and metabolism.

Anti-CD38 antibody-mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cells.

J. Gribben, T. A. Lister, J. Cavenagh, 2008, Blood.

Proteomic and genomic integration identifies kinase and differentiation determinants of kinase inhibitor sensitivity in leukemia cells

J. Fitzgibbon, V. Rajeeve, P. Cutillas, 2017, Leukemia.

Arginine deprivation using pegylated arginine deiminase has activity against primary acute myeloid leukemia cells in vivo.

J. Gribben, J. Cavenagh, P. Szlosarek, 2015, Blood.

Effect of severe growth hormone (GH) deficiency due to a mutation in the GH-releasing hormone receptor on insulin-like growth factors (IGFs), IGF-binding proteins, and ternary complex formation throughout life.

P. Clayton, M. Levine, S. Shalet, 1999, The Journal of clinical endocrinology and metabolism.

Leukemia-initiating cells from some acute myeloid leukemia patients with mutated nucleophosmin reside in the CD34(-) fraction.

J. Gribben, T. A. Lister, J. Cavenagh, 2010, Blood.

Integrative phosphoproteomics defines two biologically distinct groups of KMT2A rearranged acute myeloid leukaemia with different drug response phenotypes

J. Gribben, J. Fitzgibbon, V. Rajeeve, 2022, bioRxiv.

An intronic growth hormone receptor mutation causing activation of a pseudoexon is associated with a broad spectrum of growth hormone insensitivity phenotypes.

P. Clayton, L. Metherell, A. David, 2007, The Journal of clinical endocrinology and metabolism.

overexpression in acute promyelocytic leukemia Loss of imprinting at the 14 q 32 domain is associated with microRNA

J. Gribben, D. Grimwade, B. Young, 2014 .

Adipocytes disrupt the translational programme of acute lymphoblastic leukaemia to favour tumour survival and persistence

J. Gribben, J. Cavenagh, B. Peck, 2021, Nature Communications.

Identification and characterisation of a novel GHR defect disrupting the polypyrimidine tract and resulting in GH insensitivity

L. Metherell, A. David, M. Savage, 2010, European journal of endocrinology.

Dehydroepiandrosterone improves psychological well-being in male and female hypopituitary patients on maintenance growth hormone replacement.

J. Monson, A. Brooke, C. Camacho‐Hübner, 2006, The Journal of clinical endocrinology and metabolism.

Proteomic and genomic integration identifies kinase and differentiation determinants of kinase inhibitor sensitivity in leukemia cells.

J. Fitzgibbon, V. Rajeeve, P. Cutillas, 2017, Leukemia.

Repression of sphingosine kinase (SK)-interacting protein (SKIP) in acute myeloid leukemia diminishes SK activity and its re-expression restores SK function

J. Gribben, S. Joel, Paul Smith, 2020, The Journal of Biological Chemistry.

Pharmacokinetic Studies Of Rhigf-I/Rhigfbp-3 Complex Administered To Patients With Growth Hormone Insensitivity Syndrome

M. Preece, A. Rogol, H. Storr, 2006 .

Insulin-like growth factor-I deficiency caused by a partial deletion of the IGF-I gene: effects of rhIGF-I therapy.

A. Clark, C. Camacho‐Hübner, M. Savage, 1999, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

Integrative phosphoproteomics defines two biologically distinct groups of KMT2A rearranged acute myeloid leukaemia with different drug response phenotypes

J. Gribben, J. Fitzgibbon, V. Rajeeve, 2023, Signal Transduction and Targeted Therapy.

Acute myeloid leukemia does not deplete normal hematopoietic stem cells but induces cytopenias by impeding their differentiation

J. Gribben, J. Cavenagh, D. Bonnet, 2013, Proceedings of the National Academy of Sciences.